Molecular Pharmacology (USA), Ltd.

MLPHOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$111554

P/E Ratio—

52W High$0.0097

52W Low$0.0001

Avg Volume11K

Open$0.00

Beta-1.41

SEC Filings

Foreign Private Issuer · Files 20-F / 6-K

Molecular Pharmacology (USA), Ltd. (MLPH) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001191357 · MLPH · OTC · as of Jun 9, 2026

Filing snapshot

112

Total Filings

15-12G

Latest Form

2015-03-05

Most Recent

2009

Filing Since

Financials Earnings View All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001191357 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY

Filed Date

2014-09-08

Fiscal Year End

Sep 8, 2014

Accession No.

0001221508-14-000021

Primary Document

form10k_06302014.htm

View on SEC EDGAR Download PDF Filing Index

Source: data.sec.gov · CIK 0001191357 · Accession 0001221508-14-000021

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report

MLPH FORM 8K

2013-07-19Material Event

View 8-K on SEC

Form 4Insider Activity

Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144

Filed Date

Form Type

Description

View

2015-03-05

15-12G

MLPH - FORM 15

0001221508-15-000004

View

15-12G15-12G

MLPH - FORM 15

2015-03-05

View

2015-02-17

NT 10-Q

MLPH - FORM 12B-25 - DECEMBER 31, 2014

0001221508-15-000002

View

NT 10-QNT 10-Q

MLPH - FORM 12B-25 - DECEMBER 31, 2014

2015-02-17

View

2014-11-13

10-Q

Quarterly Report

MLPH FORM 10-Q 09-30-2014

0001221508-14-000024

View

10-QQuarterly Report

MLPH FORM 10-Q 09-30-2014

2014-11-13

View

2014-09-08

10-K

Annual Report

MLPH FORM 10-K - 06-30-2014

0001221508-14-000021

View

10-KAnnual Report

MLPH FORM 10-K - 06-30-2014

2014-09-08

View

2014-05-06

10-Q

Quarterly Report

MLPH FORM 10Q 03-31-2014

0001221508-14-000007

View

10-QQuarterly Report

MLPH FORM 10Q 03-31-2014

2014-05-06

View

2014-02-11

10-Q

Quarterly Report

MLPH FORM 10Q 12-31-2013

0001221508-14-000003

View

10-QQuarterly Report

MLPH FORM 10Q 12-31-2013

2014-02-11

View

2013-10-31

10-Q

Quarterly Report

MLPH FORM 10-Q 09-30-2013

0001221508-13-000015

View

10-QQuarterly Report

MLPH FORM 10-Q 09-30-2013

2013-10-31

View

2013-08-13

10-K

Annual Report

MLPH FORM 10K 06-30-2013

0001221508-13-000012

View

10-KAnnual Report

MLPH FORM 10K 06-30-2013

2013-08-13

View

2013-07-19

8-K

Current Report

MLPH FORM 8K

0001221508-13-000009

View

8-KCurrent Report

MLPH FORM 8K

2013-07-19

View

2013-05-08

10-Q/A

Quarterly Report (Amended)

FORM 10-Q/A-1 FOR PERIOD ENDED MARCH 31, 2013 TO SEND XBRL

0001221508-13-000008

View

10-Q/AQuarterly Report (Amended)

FORM 10-Q/A-1 FOR PERIOD ENDED MARCH 31, 2013 TO SEND XBRL

2013-05-08

View

2013-05-08

10-Q

Quarterly Report

FORM 10-Q FOR PERIOD ENDED MARCH 31, 2013

0001221508-13-000007

View

10-QQuarterly Report

FORM 10-Q FOR PERIOD ENDED MARCH 31, 2013

2013-05-08

View

2013-02-12

10-Q/A

Quarterly Report (Amended)

MLPH FORM 10 Q/A1 2012-12-31

0001221508-13-000006

View

10-Q/AQuarterly Report (Amended)

MLPH FORM 10 Q/A1 2012-12-31

2013-02-12

View

2013-02-08

10-Q

Quarterly Report

MLPH FORM 10 Q 2012-12-31

0001221508-13-000002

View

10-QQuarterly Report

MLPH FORM 10 Q 2012-12-31

2013-02-08

View

2012-11-08

10-Q

Quarterly Report

MLPH FORM 10 Q 2012-09-30

0001221508-12-000017

View

10-QQuarterly Report

MLPH FORM 10 Q 2012-09-30

2012-11-08

View

2012-08-22

10-K

Annual Report

MLPH FORM 10 K 06-30-2012

0001221508-12-000015

View

10-KAnnual Report

MLPH FORM 10 K 06-30-2012

2012-08-22

View

Showing 1–15 of 112 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov) | Updated: Hourly | CIK: 0001191357 | Exchange: OTC · Healthcare

Molecular Pharmacology (USA), Ltd. (OTC: MLPH) has submitted 112 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2009. As a Healthcare sector company with CIK 0001191357, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Molecular Pharmacology (USA), Ltd.'s most comprehensive regulatory disclosure. The most recent Molecular Pharmacology (USA), Ltd. 10-K was filed on 2014-09-08 for fiscal year ending 2014. Historical MLPH 10-K annual reports are available from 2003 through 2014.

Investors researching Molecular Pharmacology (USA), Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Related Companies SEC Filings — Healthcare

ACBM SEC Filings →NSPDF SEC Filings →BSSP SEC Filings →LADX SEC Filings →NUNZ SEC Filings →AFFY SEC Filings →AMBS SEC Filings →NNBP SEC Filings →

→ MLPH Financials → MLPH Earnings → MLPH Insider Trades

Frequently Asked Questions

MLPH SEC Filings · 8 questions

Molecular Pharmacology (USA), Ltd. (MLPH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 112 filings and access original documents at no cost. Molecular Pharmacology (USA), Ltd.'s CIK is 0001191357.

MLPH SEC filingsMolecular Pharmacology (USA), Ltd. SEC documentsfind MLPH 10-K